Large gap with delayed quotes
|
Last quote
04/27/2026
-
18:02:25
|
Bid
04/27/2026 -
18:02:52
|
Bid Volume |
Ask
04/27/2026 -
18:02:52
|
Ask Volume |
|---|---|---|---|---|
|
46.07
+0.01
(
+0.02% )
|
45.96
|
100 |
46.17
|
100 |
Analysis date: 24.04.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 31.03.2026.
Interest
Strong
Strong
Three stars since 27.03.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 07.11.2025 at a price of 73.72.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 27.03.2026.
4wk Rel Perf
26.91%
26.91%
The four-week dividend-adjusted overperformance versus SP500 is 26.91%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 29.08.2025.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 1.07%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.78%.
Mkt Cap in $bn
4.94
4.94
With a market capitalization between $2 & $8bn, CORCEPT THERAPEUTICS is considered a mid-cap stock.
G/PE Ratio
1.32
1.32
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
4.56
4.56
The estimated PE is for the year 2029.
LT Growth
6.03%
6.03%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
138
138
For 1% of index variation, the stock varies on average by 1.38%.
Correlation
0.23
0.23
Stock movements are strongly independent of index variations.
Value at Risk
42.35
42.35
The value at risk is estimated at USD 42.35. The risk is therefore 91.96%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025